Literature DB >> 1711733

Well-differentiated hepatocellular carcinoma associated with long-term survival. Report of two cases.

M Loda1, A E Mendoza, C O'Hara, J M Crawford, M Federman, H Goodman.   

Abstract

Two cases of well-differentiated hepatocellular carcinoma (HCC) with focal biliary differentiation are presented. The distinct histological features of these neoplasms and the unusually protracted clinical course of 8 and 10 years distinguish them from previously described pathological categories of primary hepatic tumors. Electron microscopic and immunohistochemical findings support a dual hepatic and bile duct differentiation of the tumor cells. If additional examples of this tumor are found to be associated with a similarly prolonged symptom-free survival, the distinction of this entity from traditional, rapidly fatal HCC becomes important. Less aggressive therapeutic options may be entertained.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711733     DOI: 10.1007/bf01606507

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  22 in total

1.  Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.

Authors:  Z D Goodman; K G Ishak; J M Langloss; I A Sesterhenn; L Rabin
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

2.  Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study.

Authors:  P Van Eyken; R Sciot; A Paterson; F Callea; M C Kew; V J Desmet
Journal:  Hum Pathol       Date:  1988-05       Impact factor: 3.466

3.  Pseudoglandular hepatocellular carcinoma. A morphogenetic study.

Authors:  Y Kondo; T Nakajima
Journal:  Cancer       Date:  1987-09-01       Impact factor: 6.860

4.  Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.

Authors:  A J Balaton; M Nehama-Sibony; C Gotheil; P Callard; E E Baviera
Journal:  J Pathol       Date:  1988-12       Impact factor: 7.996

5.  Antigenic markers of hepatocellular carcinoma.

Authors:  A Chedid; G Chejfec; M Eichorst; F Villamil; R Terg; M Telenta; R Hojman
Journal:  Cancer       Date:  1990-01-01       Impact factor: 6.860

6.  The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.

Authors:  C Brumm; C Schulze; K Charels; T Morohoshi; G Klöppel
Journal:  Histopathology       Date:  1989-05       Impact factor: 5.087

7.  Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.

Authors:  J R Craig; R L Peters; H A Edmondson; M Omata
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

8.  Hepatocellular carcinoma. A clinical and pathologic analysis of 57 hepatectomy cases.

Authors:  K Kishi; T Shikata; S Hirohashi; H Hasegawa; S Yamazaki; M Makuuchi
Journal:  Cancer       Date:  1983-02-01       Impact factor: 6.860

9.  Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications.

Authors:  H C Hsu; T T Wu; M Z Wu; J C Sheu; C S Lee; D S Chen
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

10.  Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.

Authors:  I A Koelma; M Nap; S Huitema; R A Krom; H J Houthoff
Journal:  Arch Pathol Lab Med       Date:  1986-11       Impact factor: 5.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.